Article: Anti-HIV gel shows promise in Aids prevention.

Washington, Feb 10 (ANI): In the first human clinical trial of its kind, a vaginal gel intended to prevent HIV infection in women has shown promise in fighting against the infection.

Called PRO 2000 (Indevus Pharmaceuticals, Inc., Lexington, Mass.), the microbicide gel was found to be safe and approximately 30 percent effective.

A microbicide is a gel, foam or cream intended to prevent the sexual transmission of HIV and other sexually transmitted infections is applied topically inside the vagina or rectum.

The clinical trial, which enrolled more than 3,000 women and conducted in Africa and the United States, suggested that PRO 2000 might ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!